Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Nov 26, 2024; 16(11): 660-664
Published online Nov 26, 2024. doi: 10.4330/wjc.v16.i11.660
Published online Nov 26, 2024. doi: 10.4330/wjc.v16.i11.660
Kill two birds with one stone: Hapatologist’s approach to metabolic dysfunction-associated steatotic liver disease and heart failure
Yusuke Hirao, Clarke Morihara, Department of Medicine, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, United States
Tomoki Sempokuya, Division of Gastroenterology and Hepatology, Department of Medicine, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, United States
Author contributions: Hirao Y, Clarke M, and Sempokuya T contributed to the literature review, manuscript drafting, and editing; Sempokuya T contributed to article supervision; all of the authors have approved the final version of the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tomoki Sempokuya, MD, Assistant Professor, Division of Gastro enterology and Hepatology, Department of Medicine, John A Burns School of Medicine, University of Hawaii at Manoa, 550 S Beretania Street, No. 501, Honolulu, HI 96813, United States. tsempoku@hawaii.edu
Received: May 11, 2024
Revised: September 25, 2024
Accepted: October 21, 2024
Published online: November 26, 2024
Processing time: 172 Days and 23.9 Hours
Revised: September 25, 2024
Accepted: October 21, 2024
Published online: November 26, 2024
Processing time: 172 Days and 23.9 Hours
Core Tip
Core Tip: Due to common risk factors and underlying pathophysiologic mechanisms, there is a significant association between heart failure with reduced ejection fraction and metabolic dysfunction-associated steatotic liver disease. This article will explore the current pharmacological and non-pharmacological interventions.